Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Clinical trials of Cry j 1 and Cry j 2 T-cell epitope peptide-expressing rice in patients with Japanese cedar pollinosis.

Hashimotoi Y, Kawata M, Mino N, Ogino S, Takeda N, Kawashima K, Takagi H, Wakasa Y, Takano M, Tanaka M, Tohda Y, Tanaka T.

Asian Pac J Allergy Immunol. 2019 Oct 6. doi: 10.12932/AP-050619-0575. [Epub ahead of print]

PMID:
31586486
2.

Efficacy and Safety of HDM SLIT Tablet in Japanese Adults with Allergic Asthma.

Tanaka A, Tohda Y, Okamiya K, Azuma R, Terada I, Adachi M.

J Allergy Clin Immunol Pract. 2019 Sep 18. pii: S2213-2198(19)30779-2. doi: 10.1016/j.jaip.2019.09.002. [Epub ahead of print]

PMID:
31541768
3.

The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia.

Yamazaki R, Nishiyama O, Saeki S, Sano H, Iwanaga T, Tohda Y.

PLoS One. 2019 Aug 19;14(8):e0212810. doi: 10.1371/journal.pone.0212810. eCollection 2019.

4.

The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients.

Iwanaga T, Tohda Y, Nakamura S, Suga Y.

Clin Drug Investig. 2019 Aug 3. doi: 10.1007/s40261-019-00835-z. [Epub ahead of print] Review.

PMID:
31377981
5.

Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan.

Nagase H, Adachi M, Matsunaga K, Yoshida A, Okoba T, Hayashi N, Emoto K, Tohda Y.

Allergol Int. 2019 Jul 13. pii: S1323-8930(19)30077-2. doi: 10.1016/j.alit.2019.06.003. [Epub ahead of print]

6.

Asthma exacerbations in patients with asthma and rhinitis: Factors associated with asthma exacerbation and its effect on QOL in patients with asthma and rhinitis.

Ohta K, Tanaka H, Tohda Y, Kohrogi H, Chihara J, Sakakibara H, Adachi M, Tamura G.

Allergol Int. 2019 Oct;68(4):470-477. doi: 10.1016/j.alit.2019.04.008. Epub 2019 Jun 6.

7.

Deep learning facilitates the diagnosis of adult asthma.

Tomita K, Nagao R, Touge H, Ikeuchi T, Sano H, Yamasaki A, Tohda Y.

Allergol Int. 2019 Oct;68(4):456-461. doi: 10.1016/j.alit.2019.04.010. Epub 2019 May 30.

8.

Characteristics and association with survival of respiratory-related hospitalization in Japanese idiopathic pulmonary fibrosis patients.

Nishiyama O, Saeki S, Yamazaki R, Sano H, Iwanaga T, Kume H, Tohda Y.

Respir Investig. 2019 Sep;57(5):415-421. doi: 10.1016/j.resinv.2019.03.005. Epub 2019 Apr 16.

PMID:
31003952
9.

Biologic-induced urticaria due to polysorbate 20.

Kato M, Oiso N, Uchida S, Yanagihara S, Sano H, Tohda Y, Kawada A.

J Dermatol. 2019 Jul;46(7):e230-e232. doi: 10.1111/1346-8138.14808. Epub 2019 Feb 13. No abstract available.

PMID:
30758866
10.

Accuracy of objective tests for diagnosing adult asthma in symptomatic patients: A systematic literature review and hierarchical Bayesian latent-class meta-analysis.

Sano H, Tomita K, Sano A, Saeki S, Nishikawa Y, Nishiyama O, Iwanaga T, Tohda Y.

Allergol Int. 2019 Apr;68(2):191-198. doi: 10.1016/j.alit.2018.08.013. Epub 2018 Oct 8.

11.

Association of short-term ozone exposure with pulmonary function and respiratory symptoms in schoolchildren:A panel study in a western Japanese city.

Kurai J, Noma H, Sano H, Iwat K, Tohda Y, Watanabe M.

J Med Invest. 2018;65(3.4):236-241. doi: 10.2152/jmi.65.236.

12.

Paraneoplastic pemphigus presenting lichen planus-like lesions.

Okahashi K, Oiso N, Ishii N, Uchida S, Yanagihara S, Sano A, Tohda Y, Hashimoto T, Tsuruta D, Kawada A.

J Dermatol. 2019 Apr;46(4):e140-e142. doi: 10.1111/1346-8138.14639. Epub 2018 Sep 14. No abstract available.

PMID:
30216496
13.

Involvement of Allosteric Effect and KCa Channels in Crosstalk between β₂-Adrenergic and Muscarinic M₂ Receptors in Airway Smooth Muscle.

Kume H, Nishiyama O, Isoya T, Higashimoto Y, Tohda Y, Noda Y.

Int J Mol Sci. 2018 Jul 9;19(7). pii: E1999. doi: 10.3390/ijms19071999.

14.

Examination of the cut-off values for a questionnaire used to evaluate asthma control in Japanese asthma patients.

Tohda Y, Hozawa S, Tanaka H.

Allergol Int. 2019 Jan;68(1):46-51. doi: 10.1016/j.alit.2018.05.007. Epub 2018 Jun 18.

15.

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.

Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A.

N Engl J Med. 2018 Jun 28;378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21.

16.

Physical activity in daily life in patients with idiopathic pulmonary fibrosis.

Nishiyama O, Yamazaki R, Sano H, Iwanaga T, Higashimoto Y, Kume H, Tohda Y.

Respir Investig. 2018 Jan;56(1):57-63. doi: 10.1016/j.resinv.2017.09.004. Epub 2017 Oct 23.

PMID:
29325683
17.

Post-herpes zoster sarcoidosis as a recurrence.

Yamauchi K, Oiso N, Iwanaga T, Tatsumi Y, Matsumura I, Tohda Y, Kawada A.

J Dermatol. 2018 Jun;45(6):e150-e151. doi: 10.1111/1346-8138.14211. Epub 2018 Jan 9. No abstract available.

PMID:
29318641
18.

The current state and provisions for elderly patients with asthma.

Iwanaga T, Sano H, Tohda Y.

J Gen Fam Med. 2017 May 23;18(3):102-107. doi: 10.1002/jgf2.6. eCollection 2017 Jun.

19.

Incidental Case of Relapsing Polychondritis Detected by 18F-FDG PET/CT.

Kaida H, Ishii K, Hanada S, Tohda Y, Murakami T.

Clin Nucl Med. 2018 Jan;43(1):25-27. doi: 10.1097/RLU.0000000000001890.

PMID:
29189373
20.

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma.

Ohta K, Adachi M, Tohda Y, Kamei T, Kato M, Mark Fitzgerald J, Takanuma M, Kakuno T, Imai N, Wu Y, Aurivillius M, Goldman M.

Allergol Int. 2018 Apr;67(2):266-272. doi: 10.1016/j.alit.2017.10.004. Epub 2017 Nov 8.

21.

Estimation of the effects of heavy Asian dust on respiratory function by definition type.

Kurai J, Watanabe M, Noma H, Iwata K, Taniguchi J, Sano H, Tohda Y, Shimizu E.

Genes Environ. 2017 Nov 1;39:25. doi: 10.1186/s41021-017-0085-9. eCollection 2017.

22.

Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?

Muraki M, Gose K, Hanada S, Sawaguchi H, Tohda Y.

Drug Deliv. 2017 Nov;24(1):1395-1400. doi: 10.1080/10717544.2017.1378937.

PMID:
28929816
23.

Development of a questionnaire to evaluate asthma control in Japanese asthma patients.

Tohda Y, Hozawa S, Tanaka H.

Allergol Int. 2018 Jan;67(1):131-137. doi: 10.1016/j.alit.2017.06.013. Epub 2017 Sep 1.

24.

Interstitial pneumonia with autoimmune features.

Nishiyama O, Tohda Y.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(3):139-144. doi: 10.2177/jsci.40.139. Review. Japanese.

25.

Association of Short-Term Exposure to Ambient Fine Particulate Matter with Skin Symptoms in Schoolchildren: A Panel Study in a Rural Area of Western Japan.

Watanabe M, Noma H, Kurai J, Sano H, Iwata K, Hantan D, Tohda Y, Shimizu E.

Int J Environ Res Public Health. 2017 Mar 13;14(3). pii: E299. doi: 10.3390/ijerph14030299.

26.

IL4Rα and ADAM33 as genetic markers in asthma exacerbations and type-2 inflammatory endotype.

Sunadome H, Matsumoto H, Petrova G, Kanemitsu Y, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Hirota T, Tamari M, Yokoyama T, Niimi A, Izuhara K, Mishima M.

Clin Exp Allergy. 2017 Aug;47(8):998-1006. doi: 10.1111/cea.12927. Epub 2017 Apr 21.

PMID:
28326636
27.

Japanese guidelines for adult asthma 2017.

Ichinose M, Sugiura H, Nagase H, Yamaguchi M, Inoue H, Sagara H, Tamaoki J, Tohda Y, Munakata M, Yamauchi K, Ohta K; Japanese Society of Allergology.

Allergol Int. 2017 Apr;66(2):163-189. doi: 10.1016/j.alit.2016.12.005. Epub 2017 Feb 11. Review.

28.

Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes.

Matsumoto H, Kanemitsu Y, Nagasaki T, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Izuhara Y, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Ono J, Ohta S, Hirota T, Kawaguchi T, Tamari M, Yokoyama T, Tabara Y, Matsuda F, Izuhara K, Niimi A, Mishima M.

Ann Allergy Asthma Immunol. 2017 Feb;118(2):197-203. doi: 10.1016/j.anai.2016.11.013. Epub 2016 Dec 27.

PMID:
28034578
29.

Clinical Features and Outcomes of IPF Patients Hospitalized for Pulmonary Infection: A Japanese Cohort Study.

Yamazaki R, Nishiyama O, Sano H, Iwanaga T, Higashimoto Y, Kume H, Tohda Y.

PLoS One. 2016 Dec 13;11(12):e0168164. doi: 10.1371/journal.pone.0168164. eCollection 2016.

30.

Improved quality of life in asthma patients under long-term therapy: Assessed by AHQ-Japan.

Tohda Y, Iwanaga T, Sano H, Kume H, Hirata K, Ohkura N, Tachibana I, Nishimura Y, Matsumoto H, Minakata Y, Yoshikawa M, Fujimura M; Kansai & Hokuriku Academy for Asthma Treatment.

Int J Clin Pract. 2017 Jan;71(1). doi: 10.1111/ijcp.12898. Epub 2016 Dec 9.

PMID:
27933734
31.

Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis.

Nishiyama O, Yamazaki R, Sano H, Iwanaga T, Higashimoto Y, Kume H, Tohda Y.

Respirology. 2017 Apr;22(3):480-485. doi: 10.1111/resp.12941. Epub 2016 Nov 21.

PMID:
27868303
32.

Effects of Asian Dust Particles on the Early-Stage Antigen-Induced Immune Response of Asthma in NC/Nga Mice.

Kurai J, Watanabe M, Sano H, Hantan D, Tohda Y, Shimizu E.

Int J Environ Res Public Health. 2016 Nov 16;13(11). pii: E1144.

33.

Epidemiology of asthma in Japan.

Iwanaga T, Tohda Y.

Nihon Rinsho. 2016 Oct;74(10):1603-1608. Japanese.

PMID:
30551268
34.

Involvement of Ca2+ Signaling in the Synergistic Effects between Muscarinic Receptor Antagonists and β₂-Adrenoceptor Agonists in Airway Smooth Muscle.

Fukunaga K, Kume H, Oguma T, Shigemori W, Tohda Y, Ogawa E, Nakano Y.

Int J Mol Sci. 2016 Sep 21;17(9). pii: E1590.

35.

[A CASE OF PULMONARY TUBERCULOSIS WITH PANCREATIC LESION].

Sano A, Nishiyama O, Sano H, Yoshida K, Tohda Y.

Kekkaku. 2016 Sep;91(9):617-622. Japanese.

PMID:
30646465
36.

Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung Disease.

Nishiyama O, Yamazaki R, Sano H, Iwanaga T, Higashimoto Y, Kume H, Tohda Y.

Can Respir J. 2016;2016:3837182. doi: 10.1155/2016/3837182. Epub 2016 May 18.

37.

A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan.

Park HS, Kim MK, Imai N, Nakanishi T, Adachi M, Ohta K, Tohda Y; Asian Benralizumab Study Group.

Int Arch Allergy Immunol. 2016;169(3):135-45. doi: 10.1159/000444799. Epub 2016 Apr 21.

38.

Development and validation of a predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics.

Yamasaki A, Tomita K, Kato K, Fukutani K, Sano H, Tohda Y, Shimizu E.

Patient Prefer Adherence. 2016 Mar 18;10:339-44. doi: 10.2147/PPA.S98637. eCollection 2016.

39.

Obstructive lung function in idiopathic pulmonary fibrosis.

Nishiyama O, Tohda Y.

Chron Respir Dis. 2016 May;13(2):206. doi: 10.1177/1479972316629964. Epub 2016 Feb 9. No abstract available.

40.

Characteristics of phenotypes of elderly patients with asthma.

Sano H, Iwanaga T, Nishiyama O, Sano A, Higashimoto Y, Tomita K, Tohda Y.

Allergol Int. 2016 Apr;65(2):204-209. doi: 10.1016/j.alit.2015.11.007. Epub 2016 Jan 16.

41.

Long-term (52 weeks) safety and tolerability of umeclidinium in Japanese patients with chronic obstructive pulmonary disease.

Yamagata E, Soutome T, Hashimoto K, Mihara K, Tohda Y.

Curr Med Res Opin. 2016 May;32(5):967-73. doi: 10.1185/03007995.2016.1140029. Epub 2016 Feb 18.

PMID:
26782971
42.

Factors associated with the effect of pulmonary rehabilitation on physical activity in patients with chronic obstructive pulmonary disease.

Kanao K, Shiraishi M, Higashimoto Y, Maeda K, Sugiya R, Okajima S, Chiba Y, Yamagata T, Terada K, Fukuda K, Tohda Y.

Geriatr Gerontol Int. 2017 Jan;17(1):17-23. doi: 10.1111/ggi.12656. Epub 2015 Dec 4.

PMID:
26634413
43.

Exertional dyspnoea and cortical oxygenation in patients with COPD.

Higashimoto Y, Honda N, Yamagata T, Sano A, Nishiyama O, Sano H, Iwanaga T, Kume H, Chiba Y, Fukuda K, Tohda Y.

Eur Respir J. 2015 Dec;46(6):1615-24. doi: 10.1183/13993003.00541-2015. Epub 2015 Oct 22.

44.

Prognostic value of forced expiratory volume in 1 second/forced vital capacity in idiopathic pulmonary fibrosis.

Nishiyama O, Yamazaki R, Sano A, Yamagata T, Sano H, Iwanaga T, Higashimoto Y, Kume H, Tohda Y.

Chron Respir Dis. 2016 Feb;13(1):40-7. doi: 10.1177/1479972315603714. Epub 2015 Sep 15.

45.

Influence of comorbidities on the efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Higashimoto Y, Yamagata T, Maeda K, Honda N, Sano A, Nishiyama O, Sano H, Iwanaga T, Chiba Y, Fukuda K, Tohda Y.

Geriatr Gerontol Int. 2016 Aug;16(8):934-41. doi: 10.1111/ggi.12575. Epub 2015 Aug 5.

PMID:
26246006
46.

Effect of a postoperative outpatient pulmonary rehabilitation program on physical activity in patients who underwent pulmonary resection for lung cancer.

Maeda K, Higashimoto Y, Honda N, Shiraishi M, Hirohata T, Minami K, Iwasaki T, Chiba Y, Yamagata T, Terada K, Matsuo Y, Shuntoh H, Tohda Y, Fukuda K.

Geriatr Gerontol Int. 2016 May;16(5):550-5. doi: 10.1111/ggi.12505. Epub 2015 May 8.

PMID:
25953128
47.

Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.

Ohta K, Ichinose M, Tohda Y, Engel M, Moroni-Zentgraf P, Kunimitsu S, Sakamoto W, Adachi M.

PLoS One. 2015 Apr 20;10(4):e0124109. doi: 10.1371/journal.pone.0124109. eCollection 2015.

48.

Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch.

Hanada S, Wada S, Ohno T, Sawaguchi H, Muraki M, Tohda Y.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 6;10:69-77. doi: 10.2147/COPD.S73521. eCollection 2015.

49.

Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma.

Nagasaki T, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, Kita H, Tomii K, Fujimura M, Yokoyama A, Nakano Y, Hozawa S, Ito I, Oguma T, Izuhara Y, Tajiri T, Iwata T, Ono J, Ohta S, Yokoyama T, Niimi A, Mishima M.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1449-52. doi: 10.1164/rccm.201407-1290LE. No abstract available.

PMID:
25496105
50.

Cavitary pulmonary cryptococcosis with an Aspergillus fungus ball.

Makino Y, Nishiyama O, Sano H, Iwanaga T, Higashimoto Y, Kume H, Tohda Y.

Intern Med. 2014;53(23):2737-9. Epub 2014 Dec 1.

Supplemental Content

Support Center